How much funding has Valence Discovery raised?

Valence Discovery has raised $25.0M in total funding, most recently a series a round.

Who are Valence Discovery's investors?

Valence Discovery's investors include Air Street Capital, Jonathan Milner, Fifty Years, Amplitude Ventures, Phoenix Venture Partners.

When was Valence Discovery founded?

Valence Discovery was founded in 2018.

Where is Valence Discovery headquartered?

Valence Discovery is headquartered in Montréal, Quebec, Canada.

What industry is Valence Discovery in?

Valence Discovery operates in Artificial Intelligence, Data & Analytics, Healthcare.

Valence Discovery

Acquired

AI drug discovery with graph neural networks

Montréal, Canada · Founded 2018 · $25.0M raised

Artificial Intelligence

Data & Analytics

Healthcare

Headquarters: Montréal, Quebec
Founded: 2018
Business Model: B2B
Website: valencediscovery.com

Total Funding: $25.0M
Last Round: $16.5M Series AMay 2022
Rounds: 2

About

Montreal-based AI drug discovery company (acquired by Recursion Pharmaceuticals in May 2023 for $47.5M USD). Valence Labs, the rebranded research engine, develops graph neural network (GNN) foundation models for molecular property prediction and drug discovery. The company built MolGPS, a 3-billion parameter GNN model trained on 5+ million molecules, achieving state-of-the-art performance on ADMET (absorption, distribution, metabolism, excretion, toxicity), binding prediction, and molecular design benchmarks.

Summary

Valence Discovery is an Artificial Intelligence company based in Montréal, Canada, founded in 2018. It has raised $25.0M in total across 2 rounds, most recently a $16.5M Series A round in May 2022. Investors include Air Street Capital, Jonathan Milner and Fifty Years.